Ms. Yurichuk has more than 25 years of executive and entrepreneurial experience in the pharmaceutical and biotechnology industry.


In her role of consultant to corporates, she has championed the successful development of strategic clinical and commercialization plans that led to accelerated product regulatory approvals (FDA, EMA, and international markets), label expansions, licensing deals and corporate M&A transactions.


She holds a BSc Hons in Medical Microbiology from the University of Manitoba, a MBA from the International School of Management, University of Toronto and is currently completing her PhD at the ISM, Paris.